State Street’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $28.9M | Buy |
|
|||||
|
2025
Q2 | $17M | Sell |
|
|||||
|
2025
Q1 | $36.8M | Sell |
|
|||||
|
2024
Q4 | $90.6M | Sell |
|
|||||
|
2024
Q3 | $124M | Buy |
|
|||||
|
2024
Q2 | $101M | Buy |
|
|||||
|
2024
Q1 | $154M | Sell |
|
|||||
|
2023
Q4 | $134M | Sell |
|
|||||
|
2023
Q3 | $76.1M | Buy |
|
|||||
|
2023
Q2 | $95.5M | Sell |
|
|||||
|
2023
Q1 | $83.9M | Sell |
|
|||||
|
2022
Q4 | $94M | Buy |
|
|||||
|
2022
Q3 | $95.2M | Sell |
|
|||||
|
2022
Q2 | $130M | Buy |
|
|||||
|
2022
Q1 | $114M | Buy |
|
|||||
|
2021
Q4 | $97.2M | Buy |
|
|||||
|
2021
Q3 | $108M | Buy |
|
|||||
|
2021
Q2 | $103M | Buy |
|
|||||
|
2021
Q1 | $97.4M | Buy |
|
|||||
|
2020
Q4 | $134M | Sell |
|
|||||
|
2020
Q3 | $104M | Sell |
|
|||||
|
2020
Q2 | $93.4M | Sell |
|
|||||
|
2020
Q1 | $132M | Buy |
|
|||||
|
2019
Q4 | $120M | Sell |
|
|||||
|
2019
Q3 | $86.6M | Buy |
|
|||||
|
2019
Q2 | $83.9M | Sell |
|
|||||
|
2019
Q1 | $38.6M | Sell |
|
|||||
|
2018
Q4 | $39.6M | Buy |
|
|||||
|
2018
Q3 | $44.8M | Buy |
|
|||||
|
2018
Q2 | $49.4M | Buy |
|
|||||
|
2018
Q1 | $37.2M | Buy |
|
|||||
|
2017
Q4 | $15.3M | Buy |
|
|||||
|
2017
Q3 | $7.87M | Buy |
|
|||||
|
2017
Q2 | $7.29M | Buy |
|
|||||
|
2017
Q1 | $6.89M | Buy |
|
|||||
|
2016
Q4 | $6M | Buy |
|
|||||
|
2016
Q3 | $5.93M | Buy |
|
|||||
|
2016
Q2 | $5.61M | Buy |
|
|||||
|
2016
Q1 | $3.4M | Buy |
|
|||||
|
2015
Q4 | $5.16M | Buy |
|
|||||
|
2015
Q3 | $3.35M | Buy |
|
|||||
|
2015
Q2 | $4.33M | Buy |
|